Skip to content
10-K

Annual Report

ANTIVIRAL TECHNOLOGIES, INC.

0001137050-13-000127

← back to feed
Filed
Mar 26, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Dec 31, 2012 150M sh
Operating Cash Flow FY 2012 · Dec 31, 2012 −$1.21M
Operating Cash Flow FY 2012 · Dec 31, 2011 −$138.49K
Sga Expense FY 2012 · Dec 31, 2012 $2.13M
Sga Expense restated FY 2012 · Dec 31, 2011 $394.02K
Net Income FY 2012 · Dec 31, 2012 −$2.3M
Net Income FY 2012 · Dec 31, 2011 −$402.88K
Stockholders Equity FY 2012 · Dec 31, 2011 −$1.93M
Total Liabilities FY 2012 · Dec 31, 2011 $2.34M
Current Assets FY 2012 · Dec 31, 2011 $4.88K
Total Assets FY 2012 · Dec 31, 2011 $405.56K
Cash And Equivalents FY 2012 · Dec 31, 2010 $3.13K